APRIL MANN: Open Payments
NPI 1295961399 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 22 payments from 11 companies in 2025. Trend: 2023 $290 · 2024 $388 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $62 |
| PFIZER INC. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Lilly USA, LLC | 3 | $47 |
| Edwards Lifesciences Corporation | 1 | $34 |
| Boston Scientific Corporation | 1 | $20 |
| Eisai Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: JARDIANCE, NURTEC ODT, Ozempic, SAPIEN 3 Ultra RESILIA, FARXIGA, MOUNJARO, Spectra WaveWriter, Leqembi.
Industry payments across SC — which companies pay providers there.
